Robert Jabulowsky PhD

Robert Jabulowsky has more than 9 years of experience in academic translational cancer research and industrial pharmaceutical development. Dr. Jabulowsky joined BioNTech AG (Mainz, Germany) in 2012 and as Deputy Head of Project Management, he is responsible for the management and translation of innovative therapeutic concepts into clinical testing. Founded in 2008, BioNTech AG is an immunotherapy leader with bench-to-market capabilities, developing truly personalized, well-tolerated and potent treatments for cancer and other diseases. Robert Jabulowsky holds a diploma in Biology and a Ph.D. in Pharmacy from the University of Frankfurt, Germany.